PMID- 17942707 OWN - NLM STAT- MEDLINE DCOM- 20080108 LR - 20211020 IS - 0890-9369 (Print) IS - 1549-5477 (Electronic) IS - 0890-9369 (Linking) VI - 21 IP - 21 DP - 2007 Nov 1 TI - Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. PG - 2762-74 AB - Oncogenic mutations of the MLL histone methyltransferase confer an unusual ability to transform non-self-renewing myeloid progenitors into leukemia stem cells (LSCs) by mechanisms that remain poorly defined. Misregulation of Hox genes is likely to be critical for LSC induction and maintenance but alone it does not recapitulate the phenotype and biology of MLL leukemias, which are clinically heterogeneous--presumably reflecting differences in LSC biology and/or frequency. TALE (three-amino-acid loop extension) class homeodomain proteins of the Pbx and Meis families are also misexpressed in this context, and we thus employed knockout, knockdown, and dominant-negative genetic techniques to investigate the requirements and contributions of these factors in MLL oncoprotein-induced acute myeloid leukemia. Our studies show that induction and maintenance of MLL transformation requires Meis1 and is codependent on the redundant contributions of Pbx2 and Pbx3. Meis1 in particular serves a major role in establishing LSC potential, and determines LSC frequency by quantitatively regulating the extent of self-renewal, differentiation arrest, and cycling, as well as the rate of in vivo LSC generation from myeloid progenitors. Thus, TALE proteins are critical downstream effectors within an essential homeoprotein network that serves a rate-limiting regulatory role in MLL leukemogenesis. FAU - Wong, Piu AU - Wong P AD - Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA. FAU - Iwasaki, Masayuki AU - Iwasaki M FAU - Somervaille, Tim C P AU - Somervaille TC FAU - So, Chi Wai Eric AU - So CW FAU - Cleary, Michael L AU - Cleary ML LA - eng GR - R01 CA055029/CA/NCI NIH HHS/United States GR - R37 CA042971/CA/NCI NIH HHS/United States GR - CA55029/CA/NCI NIH HHS/United States GR - CA42971/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20071017 PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 0 (DNA-Binding Proteins) RN - 0 (Homeodomain Proteins) RN - 0 (MEIS1 protein, human) RN - 0 (Meis1 protein, mouse) RN - 0 (Myeloid Ecotropic Viral Integration Site 1 Protein) RN - 0 (Neoplasm Proteins) RN - 0 (Pbx2 protein, mouse) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Repressor Proteins) RN - 0 (Tgif1 protein, mouse) RN - 146150-81-4 (proto-oncogene protein Pbx3) RN - 149025-06-9 (Myeloid-Lymphoid Leukemia Protein) SB - IM EIN - Genes Dev. 2007 Nov 15;21(22):3017. So, Chai Wai Eric [corrected to So, Chi Wai Eric] CIN - Genes Dev. 2007 Nov 15;21(22):2845-9. PMID: 18006680 MH - Animals MH - *Cell Proliferation MH - Cell Transformation, Neoplastic/genetics MH - DNA-Binding Proteins/physiology MH - Gene Expression Regulation, Leukemic MH - Genes, cdc/physiology MH - Homeodomain Proteins/genetics/*physiology MH - Humans MH - K562 Cells MH - Leukemia, Myeloid, Acute/*genetics/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Myeloid Ecotropic Viral Integration Site 1 Protein MH - Myeloid-Lymphoid Leukemia Protein/*genetics MH - Neoplasm Proteins/genetics/*physiology MH - Neoplasm Transplantation/mortality MH - Neoplastic Stem Cells/*cytology/pathology MH - Proto-Oncogene Proteins/genetics/physiology MH - Repressor Proteins/*physiology MH - Time Factors MH - Tumor Cells, Cultured PMC - PMC2045130 EDAT- 2007/10/19 09:00 MHDA- 2008/01/09 09:00 PMCR- 2007/11/01 CRDT- 2007/10/19 09:00 PHST- 2007/10/19 09:00 [pubmed] PHST- 2008/01/09 09:00 [medline] PHST- 2007/10/19 09:00 [entrez] PHST- 2007/11/01 00:00 [pmc-release] AID - gad.1602107 [pii] AID - 10.1101/gad.1602107 [doi] PST - ppublish SO - Genes Dev. 2007 Nov 1;21(21):2762-74. doi: 10.1101/gad.1602107. Epub 2007 Oct 17.